tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Technical Analysis

Compare
7 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is 1.45, suggesting Basilea Pharmaceutica is a Buy.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 53.88, while Basilea Pharmaceutica’s (BSLN) share price is CHF55.4, making it a Buy.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 51.57, while Basilea Pharmaceutica’s (BSLN) share price is CHF55.4, making it a Buy.

Basilea Pharmaceutica (BSLN) Pivot Points

Jan 14, 2026, 07:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
51.43
53.27
54.33
56.17
57.23
59.07
60.13
Fibonacci
53.27
54.37
55.06
56.17
57.27
57.96
59.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Jan 14, 2026, 07:42 AM
Period
Simple
Exponential
MA5
55.54Sell
55.18Sell
MA10
55.04Sell
54.90Sell
MA20
54.08Buy
53.88Buy
MA50
50.17Buy
51.57Buy
MA100
48.79Buy
50.03Buy
MA200
48.22Buy
48.19Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 54.90, while Basilea Pharmaceutica’s (BSLN) share price is CHF55.4, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 50.03, while Basilea Pharmaceutica’s (BSLN) share price is CHF55.4, making it a Buy.
Basilea Pharmaceutica’s (BSLN) stock price is CHF55.4 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 50.17, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF55.4 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 48.79, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF55.4 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 48.22, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Jan 14, 2026, 07:42 AM
Name
Value
Implied Action
RSI (14)
53.84
Neutral
STOCH (9,6)
62.25
Neutral
STOCHRSI (14)
62.25
Neutral
MACD (12,26)
1.45
Buy
ADX (14)
30.10
Neutral
Williams %R
-63.24
Buy
CCI (14)
25.57
Neutral
ATR (14)
1.60
-
Ultimate Oscillator
54.16
Neutral
ROC
0.93
Buy
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 53.84, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 30.10, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is 25.57, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is 0.93, creating a Buy signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Buy.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 53.84, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is 1.45, which suggests BSLN is a Buy.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 55.54, which suggests BSLN is a Sell.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 54.08, which suggests BSLN is a Buy.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 50.17, which suggests BSLN is a Buy.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 48.22, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -63.24, which suggests BSLN is a Buy.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is 25.57, which suggests BSLN is a Neutral.
                    What is the share price of Basilea Pharmaceutica?